$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

$blfs Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000143774920023238 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$14.73M	$11.28M	$8.300M
YoY Change	77.47%	70.79%	52.01%
Cost Of Revenue	$6.750M	$4.826M	$3.070M
YoY Change	119.87%	130.47%	79.53%
Gross Profit	$7.970M	$6.453M	$5.230M
YoY Change	52.39%	42.77%	39.47%
Gross Profit Margin	54.11%	57.21%	63.01%
Selling, General & Admin	$6.570M	$5.091M	$3.980M
YoY Change	65.08%	41.5%	66.53%
% of Gross Profit	82.43%	78.89%	76.1%
Research & Development	$1.860M	$1.725M	$750.0K
YoY Change	148.0%	67.15%	141.94%
% of Gross Profit	23.34%	26.73%	14.34%
Depreciation & Amortization	$1.520M	$296.0K	$960.0K
YoY Change	58.33%	159.65%	860.0%
% of Gross Profit	19.07%	4.59%	18.36%
Operating Expenses	$12.47M	$6.816M	$5.860M
YoY Change	112.8%	-7.59%	117.04%
Operating Profit	-$4.500M	-$1.246M	-$630.0K
YoY Change	614.29%	61.4%	-160.0%
Interest Expense	$210.0K	$3.000K	$90.00K
YoY Change	133.33%	200.0%	-160.0%
% of Operating Profit
Other Income/Expense, Net	-$860.0K	$113.0K	-$12.84M
YoY Change	-93.3%	-98.98%	-54.58%
Pretax Income	-$5.390M	-$1.133M	-$13.78M
YoY Change	-60.89%	-111.03%	-49.67%
Income Tax	-$3.260M	$0.00	-$1.540M
% Of Pretax Income
Net Earnings	-$2.130M	-$1.133M	-$12.24M
YoY Change	-82.6%	-111.03%	-55.3%
Net Earnings / Revenue	-14.46%	-10.05%	-147.47%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share	-$64.60K	-$0.04	-$593.3K
COMMON SHARES
Basic Shares Outstanding	32.74M	31.64M	20.45M
Diluted Shares Outstanding		31.64M

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$90.40M	$94.00M	$6.400M
YoY Change	1312.5%	343.4%	-79.15%
Cash & Equivalents	$90.40M	$93.98M	$6.448M
Short-Term Investments
Other Short-Term Assets	$4.700M	$16.70M	$1.300M
YoY Change	261.54%	1755.56%	225.0%
Inventory	$11.60M	$11.04M	$10.97M
Prepaid Expenses
Receivables	$8.006M	$6.095M	$5.345M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$114.7M	$127.8M	$24.11M
YoY Change	375.73%	298.49%	-35.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.12M	$5.300M	$5.572M
YoY Change	81.62%	148.13%	322.44%
Goodwill	$58.45M	$33.51M	$33.64M
YoY Change	73.76%	18.22%
Intangibles	$31.05M	$19.88M	$21.98M
YoY Change	41.25%	23.84%
Long-Term Investments	$5.900M	$54.00K
YoY Change		-94.6%
Other Assets	$200.0K	$0.00	$100.0K
YoY Change	100.0%
Total Long-Term Assets	$120.1M	$68.10M	$68.70M
YoY Change	74.84%	31.67%	769.33%
TOTAL ASSETS
Total Short-Term Assets	$114.7M	$127.8M	$24.11M
Total Long-Term Assets	$120.1M	$68.10M	$68.70M
Total Assets	$234.8M	$195.9M	$92.82M
YoY Change	153.0%	133.79%	104.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.672M	$2.355M	$3.119M
YoY Change	17.73%	50.0%	333.19%
Accrued Expenses	$472.0K	$3.364M	$301.0K
YoY Change	56.81%	423.99%	-75.31%
Deferred Revenue	$931.0K	$334.0K	$324.0K
YoY Change	187.35%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$614.0K
YoY Change
Total Short-Term Liabilities	$15.57M	$8.362M	$7.669M
YoY Change	103.06%	66.77%	295.51%
LONG-TERM LIABILITIES
Long-Term Debt	$655.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$71.00K	$262.0K	$4.000K
YoY Change	1675.0%	8633.33%	-98.95%
Total Long-Term Liabilities	$726.0K	$262.0K	$4.000K
YoY Change	18050.0%	8633.33%	-98.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.57M	$8.362M	$7.669M
Total Long-Term Liabilities	$726.0K	$262.0K	$4.000K
Total Liabilities	$29.58M	$9.036M	$49.36M
YoY Change	-40.07%	-81.41%	60.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$97.39M	-$95.26M	-$100.1M
YoY Change	-2.67%	-7.55%	1.68%
Common Stock	$302.6M	$282.1M	$143.5M
YoY Change	110.88%	104.09%	26.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$205.2M	$186.9M	$43.45M
YoY Change
Total Liabilities & Shareholders Equity	$234.8M	$195.9M	$92.82M
YoY Change	153.0%	133.79%	104.14%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	-$2.130M	-$1.133M	-$12.24M
YoY Change	-82.6%	-111.03%	-55.3%
Depreciation, Depletion And Amortization	$1.520M	$296.0K	$960.0K
YoY Change	58.33%	159.65%	860.0%
Cash From Operating Activities	$2.260M	-$500.0K	-$1.010M
YoY Change	-323.76%	-143.86%	-271.19%
INVESTING ACTIVITIES
Capital Expenditures	-$5.650M	-$480.0K	-$1.520M
YoY Change	271.71%	-11.11%	850.0%
Acquisitions
YoY Change
Other Investing Activities	-$16.41M	-$500.0K	-$12.50M
YoY Change	31.28%	-300.0%
Cash From Investing Activities	-$22.06M	-$980.0K	-$14.02M
YoY Change	57.35%	237.93%	8662.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.270M	80.59M	270.0K
YoY Change	370.37%	10790.54%	-112.62%
NET CHANGE
Cash From Operating Activities	2.260M	-500.0K	-1.010M
Cash From Investing Activities	-22.06M	-980.0K	-14.02M
Cash From Financing Activities	1.270M	80.59M	270.0K
Net Change In Cash	-18.53M	79.11M	-14.76M
YoY Change	25.54%	4875.47%	763.16%
FREE CASH FLOW
Cash From Operating Activities	$2.260M	-$500.0K	-$1.010M
Capital Expenditures	-$5.650M	-$480.0K	-$1.520M
Free Cash Flow	$7.910M	-$20.00K	$510.0K
YoY Change	1450.98%	-101.19%	-32.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	538000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1528000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	12525000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	7376000	USD
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32735912
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32131165
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32131165
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20825452
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20825452
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6200000	USD
	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	51000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93984000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6448000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	15000000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6095000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5345000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11037000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	10972000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1668000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1348000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	127784000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	24113000	USD
CY2020Q3	blfs	Assets Held For Rent Noncurrent AssetsHeldForRentNoncurrent	5131000	USD
CY2019Q4	blfs	Assets Held For Rent Noncurrent AssetsHeldForRentNoncurrent	3922000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5300000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5572000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	585000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1040000	USD
CY2020Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	35000	USD
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	50000	USD
CY2020Q3	blfs	Investments In Non Marketable Equity Securities And Available For Sale Debt Securities InvestmentsInNonMarketableEquitySecuritiesAndAvailableForSaleDebtSecurities	3610000	USD
CY2019Q4	blfs	Investments In Non Marketable Equity Securities And Available For Sale Debt Securities InvestmentsInNonMarketableEquitySecuritiesAndAvailableForSaleDebtSecurities	2500000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	54000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments		USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19882000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21982000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	33506000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	33637000	USD
CY2020Q3	us-gaap	Assets Assets	195887000	USD
CY2019Q4	us-gaap	Assets Assets	92816000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2355000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3119000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3364000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3369000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	729000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	804000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent		USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	377000	USD
CY2020Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1914000	USD
CY2019Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8362000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7669000	USD
CY2020Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	39602000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	386000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1537000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	550000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	262000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	9036000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	49362000	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	32000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	282076000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	143485000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95257000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100052000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	186851000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	43454000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195887000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92816000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11279000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6604000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	33361000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19075000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4826000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2094000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13893000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5710000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1725000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1032000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4865000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2082000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1588000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1250000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4530000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3032000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3503000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2348000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9916000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6707000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	706000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	465000	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	179000	USD
CY2019Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	291000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	417000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	34193000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	18534000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	63000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	417000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	3000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	1000	USD
	us-gaap	Interest Expense InterestExpense	4000	USD
	us-gaap	Interest Expense InterestExpense	5000	USD
CY2020Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	5000	USD
CY2019Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	13000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	9000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	13000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	110000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1246000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-772000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-832000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	541000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1005000	USD
CY2019Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1128000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4467000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	14949000	USD
CY2020Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	1110000	USD
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1110000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	16000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-291000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-739000	USD
CY2020Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	0	USD
CY2019Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	10108000	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	0	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	10108000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	113000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11041000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5627000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5181000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1133000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10269000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4795000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4640000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	10269000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4795000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4640000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8380000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4322000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4640000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8862000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	279000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4640000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31639420
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19735364
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25418375
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19071722
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31639420
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25343112
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29412538
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19071722
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	43454000	USD
	blfs	Adjustments To Additional Paid In Capital Stock Issued As Employee Bonus AdjustmentsToAdditionalPaidInCapitalStockIssuedAsEmployeeBonus	314000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100121000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3818000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1028000	USD
	blfs	Stock Issued During Period Value Cashless Warrant Exercises StockIssuedDuringPeriodValueCashlessWarrantExercises	33111000	USD
	blfs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	150000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	4795000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	186851000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	105843000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	80207000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1560000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	244000	USD
CY2020Q3	blfs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	70000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1133000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	186851000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	14632000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2179000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19932000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	841000	USD
	blfs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	2247000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4640000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	35191000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	2072000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	829000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19932000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	378000	USD
CY2019Q3	blfs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	1711000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	10269000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	35191000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4795000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4640000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1454000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	373000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	465000	USD
	blfs	Noncash Lease Expense NoncashLeaseExpense	455000	USD
	blfs	Noncash Lease Expense NoncashLeaseExpense	361000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2179000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-739000	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	-0	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	10108000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1110000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1528000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3818000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4467000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	14949000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	9000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	15000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	820000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-98000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4388000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2216000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	372000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	65000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1730000	USD
	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Longterm Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongtermDeposits	-68000	USD
	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Longterm Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongtermDeposits	272000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-604000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	377000	USD
	blfs	Increase Decrease In Other Payables IncreaseDecreaseInOtherPayables	-406000	USD
	blfs	Increase Decrease In Other Payables IncreaseDecreaseInOtherPayables	-87000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	689000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	65000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-30000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	1000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	370000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	356000	USD
	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	1791000	USD
	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	453000	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	3000	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2658000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12997000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2175000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2175000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	-0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	483000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	-0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100251000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	blfs	Proceeds From Exercise Of Common Stock Options And Warrants ProceedsFromExerciseOfCommonStockOptionsAndWarrants	1028000	USD
	blfs	Proceeds From Exercise Of Common Stock Options And Warrants ProceedsFromExerciseOfCommonStockOptionsAndWarrants	841000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	40000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	553000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	-0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	44000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-30000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-21000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1329000	USD
	blfs	Deferred Financing Cost Related To Stock Issuance DeferredFinancingCostRelatedToStockIssuance	130000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100806000	USD
	blfs	Deferred Financing Cost Related To Stock Issuance DeferredFinancingCostRelatedToStockIssuance	0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	102536000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9452000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6448000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30657000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	108984000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21205000	USD
	blfs	Cashless Exercise Of Warrants Reclassified From Warrant Liability To Common Stock CashlessExerciseOfWarrantsReclassifiedFromWarrantLiabilityToCommonStock	33111000	USD
	blfs	Cashless Exercise Of Warrants Reclassified From Warrant Liability To Common Stock CashlessExerciseOfWarrantsReclassifiedFromWarrantLiabilityToCommonStock	0	USD
	blfs	Reclassification Of Warrant Liabilities To Equity Upon Exercise ReclassificationOfWarrantLiabilitiesToEquityUponExercise	110000	USD
	blfs	Reclassification Of Warrant Liabilities To Equity Upon Exercise ReclassificationOfWarrantLiabilitiesToEquityUponExercise	1694000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	146000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	53000	USD
	us-gaap	Notes Issued1 NotesIssued1	270000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	19932000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6400000	USD
CY2020Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5951250
CY2020Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	14.50
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6100000	USD
CY2020Q3	blfs	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	80200000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	388000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	386000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><b>Concentrations of credit risk and business risk</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:justify;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2020, </em>we derived approximately 11% of our product revenue from one customer and in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2020, </em>we derived approximately 12% of our revenue from one customer. In the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2019, </em>we derived approximately 33% of our product revenue from <em style="font: inherit;">three</em> customers and in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2019, </em>we derived approximately 17% of our revenue from one customer. <em style="font: inherit;">No</em> other customer accounted for more than <em style="font: inherit;">10%</em> of revenue in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2020 </em>or <em style="font: inherit;">2019.</em> In the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2020 </em>and <em style="font: inherit;">2019,</em> we derived approximately 62% and 81%, of our revenue from CryoStor products, respectively. Due to our acquisitions in <em style="font: inherit;">2019</em> and <em style="font: inherit;">2020,</em> we expect both our revenue concentration related to CryoStor and our customer concentrations to be reduced for the year ended <em style="font: inherit;"> December 31, 2020. </em>At <em style="font: inherit;"> September 30, 2020, </em>two customers accounted for approximately 32% of total gross accounts receivable. At <em style="font: inherit;"> December 31, 2019, </em>two customers accounted for approximately 25% of total gross accounts receivable. </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The following table represents the Company’s total revenue by geographic area (based on the location of the customer):</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.4pt;margin-top:0pt;text-align:justify;"><i><b> </b></i></p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>Three Months Ended</b></b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>September 30,</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>Nine Months Ended </b></b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>September 30,</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Revenue by customers’ geographic locations</b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>2020</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>2019</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>2020</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>2019</b></b></p> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">United States</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">73</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">76</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">73</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">70</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Canada</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">12</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">13</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">17</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Europe, Middle East, Africa (EMEA)</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">13</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">12</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Total revenue</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">%</p> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">%</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:14.4pt;margin-top:0pt;text-align:justify;"> </p>
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2731000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2979000	USD
CY2020Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2252000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1896000	USD
CY2020Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6054000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6097000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11037000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	10972000	USD
CY2020Q3	blfs	Shippers Placed In Service Gross ShippersPlacedInServiceGross	4666000	USD
CY2019Q3	blfs	Shippers Placed In Service Gross ShippersPlacedInServiceGross	3073000	USD
	blfs	Shippres Placed In Service Depreciation ShippresPlacedInServiceDepreciation	-755000	USD
	blfs	Shippres Placed In Service Depreciation ShippresPlacedInServiceDepreciation	-174000	USD
CY2020Q3	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	3911000	USD
CY2019Q3	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	2899000	USD
CY2020Q3	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	1220000	USD
CY2019Q3	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	1023000	USD
CY2020Q3	blfs	Assets Held For Rent AssetsHeldForRent	5131000	USD
CY2019Q3	blfs	Assets Held For Rent AssetsHeldForRent	3922000	USD
CY2020Q3	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	186000	USD
	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	581000	USD
CY2019Q3	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	51000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21982000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	706000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	465000	USD
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P9Y
CY2020Q3	us-gaap	Goodwill Goodwill	33506000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	705000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23060000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3179000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19881000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23060000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1078000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	33637000	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-131000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2825000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2825000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2795000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2770000	USD
CY2020Q3	blfs	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	7961000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19881000	USD
CY2020Q3	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Nonvested Share Based Compensation UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicNonvestedShareBasedCompensation	0	USD
CY2019Q3	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Nonvested Share Based Compensation UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicNonvestedShareBasedCompensation	-207000	USD
	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Nonvested Share Based Compensation UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicNonvestedShareBasedCompensation	-138000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1560000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	829000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3818000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2179000	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3959005
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.33
	blfs	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	3879905
	blfs	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	4.33
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	79100
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.75
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	10269000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4795000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4640000	USD
	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Nonvested Share Based Compensation UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicNonvestedShareBasedCompensation	0	USD
CY2020Q3	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Warrants Outstanding UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicWarrantsOutstanding	0	USD
CY2019Q3	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Warrants Outstanding UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicWarrantsOutstanding	-1682000	USD
	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Warrants Outstanding UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicWarrantsOutstanding	-335000	USD
	blfs	Undistributed Earnings Loss Allocated To Participating Securities Basic Warrants Outstanding UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicWarrantsOutstanding	0	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8380000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4322000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4640000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31639420
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19735364
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25418375
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19071722
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	10269000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4795000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4640000	USD
CY2020Q3	blfs	Warrants Income Statement Impact WarrantsIncomeStatementImpact	-0	USD
CY2019Q3	blfs	Warrants Income Statement Impact WarrantsIncomeStatementImpact	279000	USD
	blfs	Warrants Income Statement Impact WarrantsIncomeStatementImpact	49000	USD
	blfs	Warrants Income Statement Impact WarrantsIncomeStatementImpact	-0	USD
CY2020Q3	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	-0	USD
CY2019Q3	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	1128000	USD
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	4467000	USD
	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	-0	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1133000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8862000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	279000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4640000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31639420
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19735364
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25418375
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19071722
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3046363
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1954137
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31639420
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25343112
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29412538
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19071722
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11279000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6604000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	33361000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19075000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.081	pure
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1300000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1800000	USD
CY2020Q3	blfs	Lease Cost Operating Leases LeaseCostOperatingLeases	229000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	170000	USD
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	59000	USD
	blfs	Lease Cost Operating Leases LeaseCostOperatingLeases	685000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	509000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	176000	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	219000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	653000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	160000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	444000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	220000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	559000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	779000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24000	USD
CY2020Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	755000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	5000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8679000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8093000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3379000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2521000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5300000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5572000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	296000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	114000	USD
	us-gaap	Depreciation Depreciation	873000	USD
	us-gaap	Depreciation Depreciation	322000	USD
CY2020Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	275000	USD
CY2019Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	302000	USD
CY2020Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	208000	USD
CY2019Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1018000	USD
CY2020Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2538000	USD
CY2019Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1554000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	334000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	324000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	171000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3364000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3369000	USD

Files In Submission

Name	View Source	Status
0001437749-20-023238-index-headers.html	Edgar Link	pending
0001437749-20-023238-index.html	Edgar Link	pending
0001437749-20-023238.txt	Edgar Link	pending
0001437749-20-023238-xbrl.zip	Edgar Link	pending
bioli20200930_10q.htm	Edgar Link	pending
bioli20200930_10qimg001.gif	Edgar Link	pending
bioli20200930_10q_htm.xml	Edgar Link	completed
blfs-20200930.xsd	Edgar Link	pending
blfs-20200930_cal.xml	Edgar Link	unprocessable
blfs-20200930_def.xml	Edgar Link	unprocessable
blfs-20200930_lab.xml	Edgar Link	unprocessable
blfs-20200930_pre.xml	Edgar Link	unprocessable
ex_211984.htm	Edgar Link	pending
ex_211985.htm	Edgar Link	pending
ex_211986.htm	Edgar Link	pending
ex_211987.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

2020 Q4 Form 10-Q Financial Statement

#000143774920023238 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS BIOLIFE SOLUTIONS INC Stock $blfs

2020 Q4 Form 10-Q Financial Statement

#000143774920023238 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs